1 hour ago
Christie Ballantyne, MD, discusses 104-week data from this 3-year extension, noting enlicitide’s sustained effects on LDL-C, non-HDL-C, apoB, and Lp(a).
23 hours ago
Children receiving 50 nmol PVX108 increased their tolerated peanut dose 2.4-fold, with no treatment-related anaphylaxis in the phase 2 trial.
November 20, 2026
Christopher Kramer, MD, discusses his substudy of SUMMIT, which utilized CMR imaging to evaluate further heart health metrics versus standard imaging.
November 20, 2026
Silent mucus plugs may flag patients with COPD at greater risk of exacerbations and death, though how to manage them remains unclear.
November 20, 2026
In VITESSE, peanut-specific IgG4 rose about 5-fold in children aged 4 to 7 years, David Fleischer, MD, told HCPLive at ACAAI 2026.